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Abstract: Graphene-based nanomaterials have been intensively studied for their properties,
modifications, and application potential. Biomedical applications are one of the main directions
of research in this field. This review summarizes the research results which were obtained in
the last two years (2017–2019), especially those related to drug/gene/protein delivery systems and
materials with antimicrobial properties. Due to the large number of studies in the area of carbon
nanomaterials, attention here is focused only on 2D structures, i.e. graphene, graphene oxide,
and reduced graphene oxide.
Keywords: graphene; graphene oxide; graphene-based nanomaterials; nanoformulations; drug
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1. Introduction
Nanomaterials are known for their outstanding physicochemical and biological properties,
which make them very desirable in material science for different applications. Graphene-based materials
(GBMs) that mainly contain zero-dimensional (0D) fullerenes, one-dimensional (1D) carbon nanotubes
(CNTs), two-dimensional (2D) graphene (GR), graphene oxide (GO), and reduced graphene oxide (rGO),
as well as their doped and functionalized derivatives, are among the most promising materials here.
GR is the basic building unit of this large group of materials, including graphite, in which the individual
GR layers are assembled into a three-dimensional (3D) structure [1,2]. GBMs are well-known to have
extraordinary electrical, optical, thermal, and mechanical properties, which makes them suitable
materials for applications in supercapacitors, ultrasensitive sensors, rapid charging/discharging
batteries, quantum physics, catalysts, advanced environmental photocatalysts, superadsorbents,
nanocomposites (NCs), chemical solar and fuel cells, optoelectronics, electronics, and others [3].
Due to their properties, GBMs provide possibilities for many applications in the biomedical field,
such as use in drug, gene, and protein delivery, photothermal therapy, as a material for building
biosensors and bioimaging, as potential antimicrobial agents, and as a scaffold for tissue engineering
and cell cultures [4,5]. Among all the named materials, 2D carbon nanostructures provide a high
specific surface area that allows for the establishment of suitable cell-substance interactions and
excellent loading efficiency due to multiple attachment spots, enabling interactions with small drug
molecules or biomolecules on the GR material surface. For this reason, GR offers better use in this area
than CNTs. Many other theranostic agents based on metal nanoparticles (NPs) and polymers have
been proposed in the biomedical field, however, the GR-based systems seem to have better stability in
the physiological environment and seem to be more biologically acceptable [6–8].
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Pure GR is a strongly hydrophobic material and requires surfaces modifications or stabilizing
agents in order to be dispersible in water. For that reason, GO and rGO are often used to improve
material properties [2]. Both materials contain functional groups on their surfaces which improve their
hydrophilic properties, and they can be further functionalized to tailor their properties for intended
purposes. On the other hand, the lipophilicity of GR can be used in membrane barrier penetration
systems [9].
This review focuses on recent advances in 2D GBM biomedical applications from the past two
years. It summarizes general facts about GBMs and their applications in this area. This summary
examines drug delivery systems (DDSs) in detail. Other areas of biomedical research are mentioned
only marginally, as research on GR and its derivatives is unstoppably fast, moving forward in each
area, where each area requires its own attention to specific detailed processing.
2. Graphene-Based Materials
GBMs have been very extensively studied in last few decades. Figure 1 shows the number of
publications in the period of 2004–2019, dealing with GR, GR in biomedical applications, and GR in
DDSs, taking into account review articles as well. According to Web of Sciences/Scopus, more than
195,900 and 144,700 research articles dealing with GR have been published in this period, respectively
(keyword “graphene”). It can be seen from the Figure 1 that GR research in general and in biomedical
applications started to increase rapidly after 2010. There is an expectation that research will continue
to evolve because of the outstanding properties of GR and derived materials. A growing trend is also
evident for research into GR applications in biomedical areas and, for example, in the application of
GR for DDSs (keywords “GR, biomedical”; “GR, biomedical, review”; “GR, drug delivery and GR,
drug delivery, review”).
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The terms GBMs or graphene family nanomaterial (GFNs) includes GR and its derivatives, such as
GO, rGO, GR/GO dots (GD/GOD), GR nano-onions, and GR nano-ribbons, as well as fullerenes,
and CNTs, see Figure 2 [10,11].Nanomaterials 2020, 10, x FOR PEER REVIEW 3 of 36 
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GR forms a basic structure of GBMs [12]. It is a 2D-planar sheet/crystal of one-atom thickness,
consisting of sp2 hybridized carbon atoms. The carbon atoms are arranged into a honeycomb lattice,
in which each carbon atom is bound to three adjoining carbon atoms via two single and one double
covalent bond [13–15]. GR can exist in a single layer, few-layered structure, or forms a graphitic
structure. GR is well-known for its exceptional and outstanding mechanical properties, such as an
exceptional structural rigidity, accompanied a fracture strength of 130 GPa, an elastic modulus of 32 GPa,
and a 1 TPa Young’s modulus. It exhibits high electrical conductivity (104 S/cm), ultra-high thermal
conductivity (5300 W/mK), and excellent electron mobility (250,000 cm2/Vs) at room temperature,
which is caused by a presence of a delocalized pi-electron system in the carbon lattice, where each
carbon atom contributes to this system by one unbound electron freely moving through the crystal.
The other significant properties are a large specific surface area of 2630 m2/g, the unusual carrier
transport velocity which reaches up to 40 GHz, the charge carrier concentration of 1.4 × 1013 cm−2,
and high-current carrying capacity of up to 109 A/cm2. Optical transmittance of 97.7% has confirmed
these superior optical properties [14,16–18].
One can imagine GR as a polycyclic aromatic macromolecule which forms a planar structure with
a large surface area, allowing the adsorption and anchoring of many compounds, such as biomolecules,
metals, and fluorescent species. The compounds can interact with the system of delocalized pi-electrons
via electrostatic interactions and non-covalent pi-pi stacking. These kinds of interactions are one of the
processes of GR surface functionalization [12,19,20].
There are several procedures for the synthesis of GR, and two major methodological approaches
can be distinguished, namely, the ‘bottom-up’ and ‘top-down’ approaches (Figure 3). There are two
main considerations for GR fabrication, namely, producing GR of high quality and simultaneously
producing said GR in a high quantity [5,14]. Several methods have been properly investigated, such as
the mechanical or chemical exfoliation of graphite, the epitaxial growth of GR on carbides of silicon,
tantalum, or titanium, or on different metal substrates, such as nickel, copper, cobalt, iridium, platinum,
etc. Other methods, such as chemical vapor deposition, solvothermal or organic synthesis could be
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also named, or synthesis of GR from graphite oxide through oxidation of graphite eventually via
un-zipping of CNTs [14,19,21].
Nanomaterials 2020, 10, x FOR PEER REVIEW 4 of 36 
 
groups, while at the edges of the flakes there are carboxylic groups [18,22,23]. This composition is a 
reason for the aforementioned hydrophilicity, the good aqueous dispersity, and the excellent ability 
to easily cross cell membranes. The functional groups also allow for the capture, anchoring, or 
immobilization of polymers or biomolecules, such as nucleic acids, as well as drugs, NPs, etc., [24] 
and, for that reason, GO is a suitable carrier for delivering proteins, peptides, RNA, DNA, and 
various molecules of biologically active substances with antiviral, antibacterial, or anticancer 
activities into cells [25]. 
 
Figure 3. Selected methods of graphene synthesis. 
For applications in the biomedical area, especially for delivering systems or antimicrobial 
materials, GO is usually synthetized from graphite using various modifications of Hummers’ 
method. One possibilities for a modified Hummers’ method is schematically shown in Figure 4. The 
effective delamination of graphite can be achieved in at a high yield by selecting suitable reagents 
and conditions for the manufacturing process. Thus, it can be produced in large quantities at 
affordable costs. The fully delaminated material may have a thickness of about 1 nm [16,19,21]. The 
polar groups are usually further modified by functionalization with the biocompatible and 
hydrophilic polymers, such as polyethylene glycole (PEG) or polyvinylpyrrolidone (PVP), then 
different drugs are loaded on the GR plane. Among GBMs, GO is an excellent material for DDSs, 
precisely because the presence of functional groups makes it easy to modify its surface [12,26]. 
The interactions of GO flakes are strongly influenced by their size. Functionalized GO flakes 
can be easily broken down to a smaller size by mild sonication and then are able to enter into cells. It 
is known that GOs with lateral dimensions higher than 100 nm do not easily penetrate into cells, 
however GO flakes of approximately 100 nm and less can readily cross the cell membrane. If the 
diameter reaches below 40 nm, their penetration in the cells may be further increased [27]. 
The reduction of GO functional groups results in rGO. The structure of rGO is similar to that of 
GR, and it is associated with its higher electrical conductivity compared to GO [5,22,28]. 
Simultaneously, due to the lower content of oxygen-containing functional groups, it is more 
hydrophobic. Large-scale rGO production is usually performed in two steps. First, the graphite is 
chemically oxidized to form GO, which is then reduced to rGO. Hydrazine is the best-known 
reductant here, however, it is poisonous and hazardous for the environment. Due to this fact, 
alternatives have been studied, such as organic acids, amino acids, proteins, sugars, 
microorganisms, plant extracts, and antioxidants, which are called “green reducing agents” [29]. 
Another method of reduction is thermal, solothermal, electrochemical, microwave, and 
photoreduction [11,19,23]. It was found in some instances that not all functional groups were 
Figure 3. Selected methods of graphene synthesis.
GO is derivative of GR. It is a flake-like material that is characterized by the occurrence of polar
oxygen-containing functional groups. The GO flakes consist of a typical graphenic planar structure,
composed of sp2 carbon atoms that is disrupted by the presence of carbon atoms in the sp3 hybridization
state. While on the planar surface, there are mainly hydroxyl and epoxy functional groups, while
at the edges of the flakes there are carboxylic groups [18,22,23]. This composition is a reason for
the aforementioned hydrophilicity, the good aqueous dispersity, and the excellent ability to easily
cross cell membranes. The functional groups also allow for the capture, anchoring, or immobilization
of polymers or biomolecules, such as nucleic acids, as well as drugs, NPs, etc., [24] and, for that
reason, GO is a suitable carrier for delivering proteins, peptides, RNA, DNA, and various molecules of
biologically active substances with antiviral, antibacterial, or anticancer activities into cells [25].
For applications in the biomedical area, especially for delivering systems or antimicrobial
materials, GO is usually synthetized from graphite using various modifications of Hummers’ method.
One possibilities for a modified Hummers’ method is schematically shown in Figure 4. The effective
delamination of graphite can be achieved in at a high yield by selecting suitable reagents and conditions
for the manufacturing process. Thus, it can be produced in large quantities at affordable costs. The fully
delaminated material may have a thickness of about 1 nm [16,19,21]. The polar groups are usually
further modified by functionalization with the biocompatible and hydrophilic polymers, such as
polyethylene glycole (PEG) or polyvinylpyrrolidone (PVP), then different drugs are loaded on the
GR plane. Among GBMs, GO is an excellent material for DDSs, precisely because the presence of
functional groups makes it easy to modify its surface [12,26].
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The interactions of GO flakes are strongly influenced by their size. Functionalized GO flakes can
be easily broken down to a smaller size by mild sonication and then are able to enter into cells. It is
known that GOs with lateral dimensions higher than 100 nm do not easily penetrate into cells, however
GO flakes of approximately 100 nm and less can readily cross the cell membrane. If the diameter
reaches below 40 nm, their penetration in the cells may be further increased [27].
The reduction of GO functional groups results in rGO. The structure of rGO is similar to that of GR,
and it is associated with its higher electrical conductivity compared to GO [5,22,28]. Simultaneously,
due to the lower content of oxygen-containing functional groups, it is more hydrophobic. Large-scale
rGO production is usually performed in two steps. First, the graphite is chemically oxidized to form GO,
which is then reduced to rGO. Hydrazine is the best-known reductant here, however, it is poisonous
and hazardous for the environment. Due to this fact, alternatives have been studied, such as organic
acids, amino acids, proteins, sugars, microorganisms, plant extracts, and antioxidants, which are called
“green reducing agents” [29]. Another method of reduction is thermal, solothermal, electrochemical,
microwave, and photoreduction [11,19,23]. It was found in some instances that not all functional
groups were eliminated during the reduction, and some of them remained preserved on the rGO basal
plane, e.g., –OH, –C–O–C–, –CO, and –COOH. The resulting properties of rGO are influenced by the
reduction ethod used and the conditions under which it is performed.
Other representatives of GBMs include fullerenes and CNTs. Fullerene is produced by spherically
wrapping 2D GR sheets into 0D closed formations [1,30]. CNTs are formed by graphenic layers
containing carbon atoms in sp2-hybridized state, which are rolled up into a hollow, cylindrical
arrangement [31–33]. Their important feature is their very high aspect ratio, which is given by their
diameter, which is in the range of several nanometers, and length, which can even reach up to
millimeters. According to chirality and possible adatoms, they have a metallic or semiconductive
character. They can effectively bind biomolecules by hydrophobic interactions, pi-pi stacking, or van der
Waals forces, similarly to GR [1]. Their properties and resulting interactions with biological systems
are influenced by many factors, such as the number of layers, the lateral dimensions, shape, purity,
and density of defects [34]. A huge number of scientific articles have been devoted to these materials
and are therefore not included in this review.
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GBMs have also received great attention in the field of biomedicine due to their exceptional
features and possible applications (Figure 5) [4].Nanomateri ls 2020, 10, x FOR PEER REVIEW 6 of 36 
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The proper characterization of materials used to explore possibilities outside of biomedical
technologies is one of the most important steps. The main reason for these proper characterizations
is that the materials are prepared in scientific laboratories as well as by different manufacturers,
using different procedures, which differ in their quality. This is further reflected in the quality of
the resulting material. Materials should be described as single-layer GR, multi-layer GR, ultra-thin
graphite, GR nanosheets, and GR nanomaterials. According to Wick et al. [35], a few-layer GR is
composed of 2–10 GR layers composed of flake-like stacks, while ultrathin graphite consists of more
than 10 layers, where the thickness is below 100 nm. This should be applied also for GO [15,35,36].
GR- and GO-based materials can be characterized according to the procedure proposed by Wick
et al. [35]. The basic qualities which should be carefully observed are the number of layers (thickness),
lateral size distribution, and C/O ratio, as is represented in Figure 6 [16,30,35]. The lateral size of GR
flakes is one of the ajor factors influencing GR properties, because differences in size and geometry
encourage a change in the ratio between the edge and the bulky structures, resulting in limited
space in specific dimensions and a consequent change in mechanical and electrical properties [37].
This characterization is very important for biomedical applications, because it is obvious that 2D GBMs
with rough surfaces, a small size, and sharp edges more readily penetrate cells as opposed to smoother
GBMs with larger dimensions. Because each carbon atom lies on the surface, these materials, especially
in the case of monolayered GR, have a theoretical maximum surface area. For that reason, they have
an exceptionally large capacity for the adsorption of molecules and biomolecules. Their capacity
corresponds to the specific surface area and bending stiffness, and is associated with the number of
layers. Obviously, more 2D GR layer material has a lower adsorption capacity [3].
Nanomaterials 2019, 9, 1758 7 of 37
Nanomaterials 2020, 10, x FOR PEER REVIEW 7 of 36 
 
 
Figure 6. Grid for the classification of GBMs, based on their atomic C/O ratio, lateral dimension, and 
number of layers. GBMs shown in the corners of the grid correspond to the ideal cases. The grid is in 
nanoscale, but one can use it for the microscale. Reprinted from [35] with permission from John 
Wiley and Sons, copyright 2019. 
3. Functionalization 
The main disadvantage concerning the applications of GBMs is solubility [46]. In general, 
materials with GR structures have limited solubility in aqueous and polar media and tend to 
aggregate through van der Waals interactions and π-π interactions [47]. While GR is a strongly 
hydrophobic material, GO containing oxygen functional groups is highly stable in water. However, 
it often undergoes aggregation when transferred to cell culture media or buffers [16,48,49]. 
Chemical modifications and the functionalization of GBMs are important methods for 
structural changes in GBM surface, which lead to an increase their solubility in biological systems 
and allow for tailoring of their interfacial and physicochemical characteristics, such as for the 
preparation of advanced functional GBMs [47,50]. There are two main groups of functionalization 
methods, namely, covalent and non-covalent functionalization. The first group of functionalization 
methods is characterized by the surface oxidation of carbon and the binding of organic/inorganic 
ions/atoms/molecules via covalent bonds, using atoms (fluorine or nitrogen), functional groups 
(hydroxyl, amino or carboxyl groups), biomolecules, or polymers, at end-caps and defect sites 
[32,51]. Consequently, the interfacial interactions of GR are highly enhanced. Typical reactions of 
covalent functionalization are nucleophilic substitution, radical and electrophilic addition, 
condensation, cycloadditions, and further derivatizations with large number of molecules or 
functionalization using cationic, anionic, and radical polymerization [1,36]. However, covalent 
functionalization alters the structure of a GBM. Functional groups form covalent bonds with the GR 
lattice, and the hybridization of some carbon atoms in the sp2 state is changed to sp3. This leads to 
disruption of the translational symmetry of GR and changes the electronic and transport properties 
of functionalized GR [52]. 
Covalent functionalization can be used not only for GR, but also in the case of GO and rGO to 
tailor their properties [53]. However, the present oxygen-containing groups have high chemical 
reactivity. Therefore, it is difficult to control the functionalization process, since different reactions 
may occur simultaneously [50]. Generally, the process enhances solubility and the dispersion of 
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iley and Sons, copyright 2019.
Analytical methods, such as scanning and transmission electron microscopy (SEM and TEM),
atomic force microscopy (AFM), infrared and/or Raman spectroscopy, X-ray photoelectron spectroscopy,
and inductively coupled plasma mass spectrometry (ICP/MS), are the most useful tools for
characterization [4,38–40]. TEM or Ra an spectroscopy and AFM allow the determination of the
number of layers and lateral dimensions. An accurate and real view of sheet quality, the number of
defects, and delamination achieved can be obtained from AFM, which allows the determination of
lateral dimensions by analyzing the shape and height of the GR/GO flakes [15,36,41–43].
There are many other methods for characterization for different purposes, for which the prepared
GR is used. Among them, dynamic light scattering, zeta potential and optical absorbance measurements,
such as UV/VIS spectroscopy, can be listed [44]. For example, UV/VIS spectroscopy can be used to
observe changes in GO structure after the functionalization of its surface. GO has a strong absorption of
UV/VIS radiation at 230 nm. Characteristic absorbance at 300 nm is done by pi→pi* transitions of C=C
bond and the n→pi* transitions of C=O bond, respectively. Upon the binding of the functional groups
to C=C bonds, a shift from 230 to 266 nm occurs, and the shoulder at 300 nm is reduced [27,40,45].
3. Functionalization
The main disadvantage concerning the applications of GBMs is solubility [46]. In general, materials
with GR structures have limited solubility in aqueous and polar media and tend to aggregate through
van der Waals interactions and pi-pi interactions [47]. While GR is a strongly hydrophobic material,
GO containing oxygen functional groups is highly stable in water. However, it often undergoes
aggregation when transferred to cell culture media or buffers [16,48,49].
Chemical modifications and the functionalization of GBMs are important methods for structural
changes in GBM surface, which lead to an increase their solubility in biological systems and allow for
tailoring of their interfacial and physicochemical characteristics, such as for the preparation of advanced
functional GBMs [47,50]. There are two main groups of functionalization methods, namely, covalent
and non-covalent functionalization. The first group of functionalization methods is characterized by
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the surface oxidation of carbon and the binding of organic/inorganic ions/atoms/molecules via covalent
bonds, using atoms (fluorine or nitrogen), functional groups (hydroxyl, amino or carboxyl groups),
biomolecules, or polymers, at end-caps and defect sites [32,51]. Consequently, the interfacial interactions
of GR are highly enhanced. Typical reactions of covalent functionalization are nucleophilic substitution,
radical and electrophilic addition, condensation, cycloadditions, and further derivatizations with large
number of molecules or functionalization using cationic, anionic, and radical polymerization [1,36].
However, covalent functionalization alters the structure of a GBM. Functional groups form covalent
bonds with the GR lattice, and the hybridization of some carbon atoms in the sp2 state is changed
to sp3. This leads to disruption of the translational symmetry of GR and changes the electronic and
transport properties of functionalized GR [52].
Covalent functionalization can be used not only for GR, but also in the case of GO and rGO
to tailor their properties [53]. However, the present oxygen-containing groups have high chemical
reactivity. Therefore, it is difficult to control the functionalization process, since different reactions may
occur simultaneously [50]. Generally, the process enhances solubility and the dispersion of GBMs in
different solvents, reduces aggregation, and also creates a gap between the conduction and valence
bands, because the Fermi level is shifted either above or below the Dirac point [46,54].
Interactions between the delocalized pi-electron system on the GR surface and structures on the
functionalizing moieties are the basis of noncovalent functionalization. These interactions include
electrostatic interactions, pi-pi stacking, van der Waals forces, hydrogen bonding, and coordination
bonds. Here, the GR pristine structure is not destroyed and its native properties are maintained,
however the forces between the GR surface and the functionalizing molecules are weak. This technique
is not satisfactory for applications requiring strong interactions [55]. The interfacial properties can be
adjusted by various polymers or surfactants. Among commonly used surfactants are sodium dodecyl
sulfate, sodium dodecyl benzene sulfate, gum arabic, Triton X-100, and cetyltrimethylammonium
bromide [46].
Functionalization is used, for example, to modify GBMs, which then carry biochemical signals that
instruct cells to heal [56]. GO or rGO are covalently functionalized through their oxygen-containing
functional groups to install bioactive molecules. Eckhart et al. used chemically altered GO for binding
hydroxyapatite-mimicking polyphosphate groups accompanied with calcium cations that stimulate
osteogenesis in vitro and support ectopic bone formation in vivo [56]. Peptide-GR conjugates are
examples of functionalization in which the biological activity of the peptide used is combined with the
exceptional properties of a GBM [56]. Pluronics™ are triblock copolymers with a back-bone composed of
(poly(ethylene oxide)-block-poly(propylene oxide)-block-poly(ethylene oxide). The functionalization
with Pluronic™ results in GR with sufficient colloidal stability, because the fragment of poly(propylene
oxide), as a hydrophobic part, interacts with the hydrophobic surface of GR, while poly(ethylene
oxide), as the hydrophilic fragment, interacts with water [57]. Amine-terminated PEG can be linked to
the carboxyl groups of GO through amide bonds. The PEGylated GO is highly dispersible in water,
as well as in more complex aqueous solutions, like serum or cell mediums. Polyvinyl alcohol forms
ester bonds directly with GO carboxyl groups, or the carboxyl groups can first be transformed into
acyl chlorides and then esterified [13].
Functionalization by metallic NPs is another promising possibility for surface treatment. At present,
the research of GR decorated with NPs is one of the most intensively studied areas. The main advantage
of anchoring metal NPs on GR plates is an increase in electrical, electrochemical, optical, and thermal
properties. The synthesis of Ag, Au, Cu, and Pt NPs of homogeneous size, as well as Au/Ag/Cu/Pt
alloys embedded on GBMs surfaces, is usually performed by the chemical reduction of cationic metal
ions (Ag+, Au3+, Cu2+, and Pt4+) [52,58].
4. Cytotoxicity and Biocompatibility
One definition of biocompatibility is that biocompatibility is the ability of materials to interact
with the living body, tissues, and cells without harmful effects [47,59]. GBMs show both possible
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effects on biological cells, where in some cases they are biocompatible, and in others they are toxic to
cells. While graphite is a well-researched, naturally occurring carbon allotrope, GR, GO and rGO are
man-prepared materials with insufficiently known effects on biological systems [1]. Their distribution
in organisms, excretion, and toxic effects are determined by their reactions with the biological system.
Previous studies have shown that the information obtained on the in vitro and in vivo toxicity of GBMs
due to their dimensions and variation in oxidation states is far from complete [60]. The interactions of
living cells with GBMs depends on their hydrophilicity, surface chemistry, purity, lateral dimensions,
layer number, and dose [61–64]. These properties vary greatly according to their synthesis eventually
to methods of functionalization.
It was proven in several studies that GR NPs increase the number of reactive oxygen species
(ROS) in cells, leading to harm to DNA, lipids, and proteins. Likewise, GR increases the rate of the cell
injuries, apoptosis, and necrosis, resulting in autolysis joined with the premature death of tissue cells.
The cellular toxicity of GR is caused by its agglomeration on cell membranes. The sharp edges of the
GR can act as knives and cut or penetrate the cell membrane, causing physical damage [65–69].
GBMs can affect cell membranes and damage them with subsequent cytotoxic effects.
Cell membranes contain phospholipids, which are composed of a head group based on phosphate
and two chains of fatty acids [61]. The head groups are formed by phosphatic acid modified also
by small molecules such as glycerol, inositol, ethanolamine, serine, or choline, which give rise to
the phospholipid distinctive properties. There are also cholesterol molecules present, for stabilizing
the membrane structure, maintaining fluidity, etc. Pristine GR is not able to electrostatically bind
phospholipids, due to lack of charge in its lattice, but it can hydrophobically interact with long chains
of the fatty acids. Membranes can be also damaged by withdrawing cholesterol molecules from the
membrane [61]. On the opposite side, GO can electrostatically interact with membrane lipids due to
the presence of oxygen-containing functional groups on its surface, contributing to a high negative
charge density. Finally, GO can directly damage the cell membrane by hydrophobic interaction without
entering the cells.
In the comparison with cell membranes at physiological pH values, due to the presence of
phosphatidylcholine liposomes of the cells, the total negative charge (ca. −20 mV) is provided [70].
In addition, the cytotoxicity depends on the charge on the surface, as mentioned below in Section 7.
Negatively charged nanoparticles show lower unfavorable effect on the cells viability because of
the negatively charged cell membrane (ca. −20 mV), which plays an important role to separate the
cytoplasm from the outside environment [71]. The positively charged surfaces are more effectively
adsorbed on the cell membrane as compared with the negatively charged or neutral ones. However,
the positively charged surfaces cause the plasma membrane disruptions, as has been reported [72].
However, GBMs also enter cytoplasm, as they possess a small size and sharp edges.
Their penetration through the cell membrane damages the membrane, and cytoplasmic content
is spilled out of the cell. Their toxic effects are manifested by mitochondrial disorders, ROS, and,
consequently, lipid peroxidation. If they penetrate the nucleus, GBMs can react with DNA and produce
genotoxic effects [61,65]. Figure 7 shows examples of the mechanisms of cytotoxic action of GBMs on
living cells [65].
GO shows significant antibacterial activity against gram-positive and gram-negative bacteria,
and, at a certain dose, it also presents cytotoxic effects in human cells [73]. GO can induce granuloma
formation in the spleen, kidneys, liver, or lungs, and it is not eliminated by the kidneys [67]. Although
there have been many demonstrations of possible applications of GO for biomedical purposes, the lack
of live cell compatibility information has curbed the scope of GO applications [73]. Cytotoxicity can be
reduced using, for example, chitosan (CS) attachment onto GO surfaces [73].
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A few studies have been conducted to compare the biocompatibility of GO and rGO, and the
results are contradictory [74]. Most studies claim that rGO-based materials are less toxic than their
parental GOs. Apparently, due to reduction of functional groups, they can have interactions with
biomolecules due to their higher hydrophobicity. Other studies have shown that rGO is more harmful
to some cells, such as U87 and U118 glioma cells, compared to GO when inducing their apoptosis [74].
In one study [67], the cytotoxic effects of GR on A549 human lung epithelial cells was investigated.
The MTT assay was used for tests of viability of the cells and the results were statistically assessed
to find the dependence between the concentration and time variables and the GR-induced death of
cells. The GR deleterious effects in A549 human lung epithelial cells have been shown to be time and
dose dependent. The highest cytotoxicity was observed after exposure for 72 h. The concentrations
corresponding to no observed adverse effect and half-maximal (50%) inhibitory concentration were
determined to be 40.653 and 0.059 µg/mL, respectively [67].
rGO was stabilized using Pluronic™P-123 (rGO-P) [57]. However, the dose-dependent cytotoxicity
of rGO-P was found in differentiated PC-12-like neuronal cells after exposure for 24 h, manifested by
membrane disruption and cytoskeletal integrity. Reactive oxidative stress in PC-12 was confirmed
as ROS production increased with increasing dose and prolonged exposure time. Acute toxicity was
evaluated in vivo using mice following the administration of rGO-P at 10 mg/kg body weight, and any
visible abnormalities in behavior and motor function, as well as other morphological changes, were not
observed [57].
The in vitro toxicity of GR and GO in three different sizes of (indicated as small, medium, and
large) on HEK 293T cells was assessed. It was observed that the large and small sizes of GR, as well as
GO, evidently diminished the viability of the cells and enhanced DNA damage. The process occurred
along with the activated generation of ROS, and various associated genetic markers expressions were
induced [60]. In addition, high GR and GO acute toxicity on Tox2 bacteria was observed. There was a
higher harmful effect of GR than GO. Moreover, this depended on the particle size. Larger particles had
stronger effects than smaller particles. In this study, it was summarized that GR significantly reduced
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survival rates and exhibited acute toxicity, and GO apparently induced DNA damage, ROS generation,
and abnormal gene expression. The induced toxicity was influenced by physical properties, mainly the
oxidation state and size, as well as concentrations of exposure, in both in vitro and in vivo assays [60].
The main barrier protecting the human body from damaging effects in the surrounding area
is human skin. It will probably react first when it comes into direct contact with GBMs. Therefore
Frontinan-Rubio et al. studied the effects of GO and GR on human HaCaT keratinocytes at the
molecular level on cell, metabolomic, Ca2+, and ROS processes, as well as cell motility and death [62].
They observed different effects of GBMs on HaCaT cells and varying amounts of metabolites occurring
in biochemical processes, for example, in butanoate metabolism, glycolysis, and the citric acid
cycle. This was probably related to variations in the global state of cell bioenergetics affecting
mitochondrial function.
The cytotoxicity of pristine GO and GO, modified with ammonia (GO-NH2), in cancerous cells
A549 of human lung tissue and human non-tumor embryonic stem Lep3 cells after exposition to
five particle concentration levels (0.1, 1, 10, 20, and 50 µg/mL) for 24 and 48 h was evaluated [63].
Characterization of the prepared GO-NH2 particles showed they possess a higher thickness but smaller
size, with a positive charge of surface and an increased ability to aggregate in cell cultures compared
to GO. It was concluded that both tested materials exhibit different cytotoxicities, which is different
for cells and depends on the dose and time of exposure. Obviously, the particles of GO-NH2 were
more cytotoxic than pristine GO. The non-tumor embryonic stem cell morphology was strongly
influenced, whereas cancerous A549 cells better withstood short-term exposure. After 48 h of exposure,
the embryonic stem cells proliferative ability remained unaffected and, on the contrary, a strong effect
on A549 cell proliferation was demonstrated [63].
Another extensive study has been performed to observe the in vitro and in vivo preclinical
biocompatibility of GBMs [47,64]. While in vitro biocompatibility assays generally consist of tests
of prokaryotic and eukaryotic cellular cytotoxicity, hemocompatibility, and inflammatory responses,
in vivo tests focus on the pharmacokinetic processes associated with GBM absorption, distribution,
metabolism, and excretion applied to organisms such as zebrafish, rats, mice, rabbits, or canines. It can
be concluded that the physicochemical properties of GBMs (functional groups present on the planar
surface, charges, structural defects, and size) contribute to determination of cellular biocompatibility.
It seems that structures with a smaller size and a higher degree of oxidation improve material
biocompatibility. GBM functionalization with macromolecules, such as PEG, proteins, dextran, and
CS, enhances the biocompatibility and attenuates cytotoxicity [47,64]. The opposite results found in a
cytotoxicity and biocompatibility study may be due to different assessments of the methodologies used.
It can be concluded that well-defined, long-term toxicity studies are needed to increase confidence in
these materials for biomedical applications [47].
5. Nanotheranostics and Tissue Engineering
The combination of therapy and diagnosis is called nanotheranostics. It involves combining
diagnosis and therapy in a single platform based on the use of nanomaterials [75]. It allows early
detection of diseases, resulting in more effective treatment. Antitumor drug targeted delivery is
made possible by the use of non-toxic nanosized carriers, using both active and passive transport
mechanisms. GBMs belong to the standard nanocarriers, together with micelles, dendrimers, liposomes,
stimuli responsive cargos, nanocantilevers, quantum dots, magnetic NPs, metal NPs, polymeric NPs,
nucleic acid based nanomaterials, etc. GBMs are very promising in this context, as the application of
metallic NPs is limited due to their stability in cells, surface chemistry, and cytotoxicity, as well as due
to their accumulation at lymph nodes, adrenals, spleen, liver, kidneys, and bone marrow.
Tissue engineering is among the prominent therapeutic approaches connecting multiple scientists
of different scientific branches. Nowadays, designing an appropriate scaffold for supporting cell
growth, with a sufficient mechanical stability to complete a process of regeneration and maintain
Nanomaterials 2019, 9, 1758 12 of 37
surgical placement is an interesting task, especially in the case of the repair of cardiovascular and
orthopedic injuries [76].
Research into the use of GBMs in tissue engineering, as well as regenerative medicine applications,
is only beginning, however, it seems to be moving forward quickly. GBMs, including CNT and GR
nanosheets, are probably the most popular among all nanomaterials that have been designed for
the controlled growth of stem cells. They have been already studied in cartilage, cardiac, neural,
musculoskeletal, bone, and skin/adipose tissue engineering [9,47].
Their superior electrical conductivity and amazing mechanical properties makes them excellent
materials for the design and manufacturing of scaffolds for artificial tissue engineering [77]. They can
be applied in cell growth and differentiation, in stem cell engineering, and wound healing, or in
regenerative medicine. They also appear to be suitable for applications as a reinforcement material
for the preparation of fibers, films, foams, hydrogels, and other tissue engineering scaffolds. Figure 8
represents nanomaterials which are used for various stem cell control growth and differentiation
methods. Among others, GR and GO have been found to enhance the growth, proliferation, and
differentiation of stem cells, such as somatic adults stem (induced pluripotent stem cells) or neural and
mesenchymal stem cells (multipotent stem cells), into specific tissue lineages [77].
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Figure 8. Nanomaterials for the selective control of stem cell growth and differentiation (a). Scaffold
materials based on graphene (GR) and GO for the culture of various stem cells, multipotent mesenchymal
stem cells (in the upper part in left, colored in yellow), neural stem cells (in the upper part, in the
middle, colored in blue) and induced pluripotent stem cells (in the upper part, colored in light blue) (b).
Reproduced from [77], with permission from Elsevier, copyright 2019.
GBMs have a number of outstanding properties which make them very suitable materials for
regenerative medicine, especially for growth of stem cells, such as their proliferation and differentiation
ability. They are also for suitable for tissue engineering [56,76]. These properties include, for example,
very good chemical stability, a large specific surface area, exceptionally good mechanical properties,
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such as perfect elasticity or rigidity in the plane, flexibility, high adaptability to flat and irregular surfaces,
exceptional electrical conductivity, the ability of mimicking biological tissue properties, and possibilities
of functionalization. They intrinsically support cell adhesion, however, biocompatibility is affected
by the particle size and surface functionalization type. By using them, tissue regeneration can be
performed in a controlled way. They can be functionalized with biocompatible substances such as
poly(acrylic acid) (PAA), dextran, or PEG. Modifications with these agents are made for the safer
implementation of GBMs in biomedical applications, where they are inert and not related to the
treatment process [56].
GR and GO have been studied as substances for bone and neural tissue engineering. It was found
that the differentiation of the stem cells was facilitated in GO because oxygen-containing functional
groups on its surface allow intermolecular interactions (electrostatic attraction, pi-pi interactions,
or hydrogen bonding) [78].
Pristine single-layer GR cytotoxicity, as well as the possibility of its application for the scaffold
preparation for the L929 mouse fibroblast cell line, was studied in [79] by observing cell viability,
cell adhesion, morphology, cytoskeleton architecture, and movement to the scratch-wound area. It was
confirmed that GR was not cytotoxic for the L929 cell line and conversely enhanced the adhesion of
cells and their proliferation within 24 h [79].
Microribbons based on the NC poly(lactide-co-glycolide)-graphene (PLGA-GR) were prepared for
neural tissue engineering, as was described in Aval et al. [80]. Different GR concentrations in the NC
and the associated effects on the mechanical, physical, chemical, and biological characteristics were
studied. GR layers were aligned in the PLGA matrix as roughness grooves on the microribbon surface.
Hydrophilicity, electrical conductivity, tensile strength, and the elastic modulus of the PLGA-GR
microribbons were all enhanced due to the incorporation of the GR nanosheets. Compared to PLGA,
a higher rate of differentiation of SH-SY5Y cells into mature neurons was achieved with PLGA-GR.
Thus, neuroblastoma cells were grown using this PLGA-GR scaffold, showing great potential for
central nerve regeneration [80].
In other work, the effects of GO derivatives on the biological, mechanical, physical, and chemical
characteristics of CS-gelatin (CS-Gel) scaffolds were studied. The polymeric chains of CS and gelatin
were modified with GO and amine-modified GO (G-NH2) via the covalent bonding of amine and
carboxylic groups. The physical and chemical properties of scaffolds, such as their density, porosity,
shape retention, interconnectivity, and capability of water absorption and retention were influenced
by surfaces with positive and negative charges of both GO and G-NH2 nanosheets compared to the
original non-functionalized CS-Gel scaffold. The mechanical properties of functionalized scaffolds and
cell viability were improved by 4–10% [76].
The biological, mechanical, physical, and chemical characteristics of scaffolds based on CS-Gel
were observed after adding GO and montmorillonite (MMT) [81]. Their presence enhanced water
absorption and retention, although the porosity of modified scaffold was lower. Compared to the CS-Gel
scaffold, a significant improvement in CS-Gel/GO/MMT mechanical characteristics was observed.
The compressive strength and Young’s modulus were increased from 0.14 to 0.23 MPa and from 17.56
to 22.73 MPa, respectively. Compared to the CS-Gel scaffold, the adsorption of protein increased
twice in CS-Gel/GO/MMT. The modified samples did not show any cytotoxicity and cell viability was
improved by 30% after 72 h of incubation [81].
One of the biggest health problems in the world is bone damage caused by traumas and sports
related injuries, as well as congenital defects [82]. A NC scaffold of gelatin, alginate, and GO (in
varying concentrations) for improving bone regeneration was prepared and tested. Compared to the
scaffold based on alginate and gelatin without GO, the compressive strength of the NC scaffold after
the incorporation of GO increased significantly. The NC was highly hydrophobic (ca. 700% of swelling)
and slowly biodegradable (ca. 30% in 28 days). Confirmation that the proposed scaffold may be a
suitable osteoinductive material was performed using in vitro studies on MG-63 cells and tests of cell
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differentiation using the mesenchymal stem cells. These tests showed an increase in both cell adhesion
and proliferation [83].
Magnetic graphene oxide (MGO) decorated by NPs of Fe3O4 was prepared to study cell behavior
and the course of osteogenic differentiation, along with the mechanism of the MGO-induced effect,
using mesenchymal stem cells derived from rat bone marrow (BMSCs). In conclusion, it was found
that MGO, at low concentrations, is biologically compatible and simultaneously notably accelerates
osteogenic differentiation in BMSCs [84].
Many new tissue engineering strategies have been proposed that largely imitate the biological
properties of body tissues that are very complex and reproducible. Hybrid scaffolds of decellularized
tissue (DT) and GO were presented in [85]. The GO concentration effects on the physical, chemical,
and structural characteristics, such as the porosity, pore size, morphology, mechanical strength,
and capacity of water uptake, have been tested. The chemical treatment of a bovine heart was used for
DT preparation. Compared to the DT scaffolds, the scaffold containing 3% GO showed a mechanical
strength and cell viability increase of about 25%. This porous scaffold promoted cellular activity and
cell adhesion and proliferation using a biomimetic construction suitable for clinical applications [85].
Hydroxyapatite, which is used as a material for bone tissue replacement, is commonly applied
for bone defects treatment due to its brilliant biocompatibility. Nevertheless, there are limitations
for its applications due to difficulty of processing and its poor osteoinductive ability. Zhou et al.
provided a method of a soft template for developing a porous scaffold characterized by a hierarchical
pore structure, which is useful for cell adhesion and ingrowth, fluid transfer, demanded porosity,
pore size, and morphology. The material also possesses sufficient biomechanical strength. The addition
of rGO promotes adhesion and proliferation, as well as the spontaneous osteogenic differentiation
of mesenchymal stem cells derived from bone marrow. Therefore, this porous hydroxyapatite/rGO
composite scaffold is capable of promoting bone growth in scaffolding and repairing severe bone
defects [86].
6. Biosensors
Biosensors based on GBMs are adaptable diagnostic tools that possess faster detection than
traditional methods. They can detect femto- or pico-molar concentrations of measured substances [87].
A chemical sensor is an instrument which is able to quantitatively/semi-quantitatively convert the
detection of a chemical into an evaluable signal [9]. Generally, these sensors are formed by a receptor
and a transducer. Any organic or inorganic substance capable of interacting with one species or
group of species can be used as the receptor. The transducer transforms chemical information into
a signal. Biosensors can be classified according to the transducer system as field-effect transistors,
resonant biosensors, optical-detection biosensors, ion-sensitive biosensors, electrochemical biosensors,
and thermal-detection biosensors. Among others, optical sensors, on the basis of metal NPs or
chromophores, or electrochemical and surface plasmon resonance (SPR) sensors, based on metal NPs,
should be named as well [9].
Based on our knowledge, GBMs are suitable candidates for the sensing of biomolecules due to
their electrical, structural, and thermal properties.
Many pathological processes in various tissues and organs are manifested by a change of a condition
in the body, such as a change in pH, temperature, ion concentration, redox state, biomolecules, and more.
The development of probes for the tracing of these changes can contribute to the explanation of intricate
biological processes [9,88]. The sensing of glucose, DNA, RNA, dopamine, the cytochrome complex,
intracellular redox state, and pH sensing in cell microenvironments can be among biochemical and
biophysical parameters which need to be monitored [78,88–93]. They can be used for the early diagnosis
of lung cancer, breast cancers, and ovarian carcinomas, or for the determination of cystadenocarcinoma
carcinoembryonic antigen (CEA). The monitoring of CEA using electrochemical immunosensors based
on GR derivatives (frequently rGO) has been described, for example, using rGO functionalized by
AuNPs and poly(l-arginine) [78].
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For example, Gao et al. studied the electrochemical interactions of dopamine (DA) and ascorbic
acid (AA) on a glassy carbon electrode (GCE) modified using GO [93]. They described a difference
in the electrochemical behavior of DA and AA on GO/GCE. It can be estimated that DA molecules,
which have a positive charge and aromatic character, easily interact with the GO/GCE interface via
pi-pi bonding and electrostatic attractive forces due to the GO surface, resulting in the production of a
large electrochemical response. AA is characterized by its non-aromatic character and does not allow
pi-pi stacking with GO. In addition, there is electrostatic repulsion between the GO surface and AA,
preventing interactions between AA and the transducer interface. This leads to the electrochemical
signal completely disappearing. Figure 9 shows a suggestion of the electrochemical behavior of
dopamine (DA) and ascorbic acid (AA) on a glassy carbon electrode (GCE) which was modified using
GO [93].
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Figure 9. Estimated electrochemistry of dopamine (DA) and ascorbic acid (AA) on a glassy carbon
electrode (GCE), modified using graphene oxide (GO/GCE). The red and blue curves (the bottom part
in left and right, respectively) correspond to the electrochemical signals of DA and AA, respectively.
Reproduced from [93], with permission from Elsevier, copyright 2019.
An advantage of GO is the presence of its hydrophobic and hydrophilic properties, which have
allowed the development of novel sensing methods, such as electrochemical detection, surface-enhanced
Raman spectroscopy, flu rescence resonance energy transfer-based bios nsors, nd laser desorption
coupled with ionization mass spectrometry [89,91].
GR-based biosensors include enzymatic electrochemical biosensors that have enzymes
imm bilized on the electrode surface and allow biomolecule detection. They are also applied
in conducting electrochemical immunosensor studies where antigen-antibody complexes are detected
on the electrode surface.
Thus, biosensors are of paramount importance biosensors due to their properties. Research on
a highly sensitive biosensor can provide new materials, which is useful for t e very sensitive
determination of various biomarkers and compounds i various areas of life science, such as biomedical,
food, agricultural, and environmental applications, along with equally important applications in
industry [87].
7. Antibacterial Properties
Similarly to various NPs, such as CNTs, metals, metal oxides, metalloids, and CS NPs, GR-based
NCs have intrinsic antimicrobial properties [92–96]. It has been confirmed that surface-immobilized GR
nanoplatelets on silicone rubber peritoneal dialysis catheters possess a strong antimicrobial effect against
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Staphylococcus epidermidis [97]. Thin films and porous membranes containing polylactic acid (PLA),
carvacrol (CRV, oregano essential oil, having antibacterial, antifungal, antioxidant, and anticancer
activities), and GR nanoplatelets were made by electrospinning and solvent casting using various
formulations. CRV releases, as a function of time, as well as the release mechanism, were studied.
The results demonstrated that the incorporation of GR nanoplatelets was associated, while reinforcing,
solidifying, strengthening, and maintaining sufficient ductility. Furthermore, the integration of GR
nanoplatelets allowed the adjustment of the amount and kinetics of the CRV liberate and decreased
the activity of the initial burst liberate [98].
Opposite observations, from the inhibition to the increased growth of bacteria, were described
as mechanisms of interaction between GO and pathogens. The influences of GO against human
pathogens were summarized. In approximately 27.8% of cases, no antibacterial effect was observed,
while in approximately 66.6% of cases a bacteriostatic effect was shown. The morphology, GO size,
concentration, exposure time, incubation protocol, and microorganism type are properties that affect
the interaction between GO and bacteria [99–101]. Many studies have verified the antibacterial efficacy
of GO in the form of freestanding paper, nanosheets, or nanowalls. It has been supposed that the
antibacterial activities are mediated by the physicochemical interactions between GO and microbial
agents. Three main mechanisms of actions were suggested, namely, nanoknives due to sharp edges,
oxidative stress, and the wrapping or trapping of bacterial membranes by flexible, thin GO films.
GO, a new antibacterial material, is preferable to other carbon-based nanomaterials, especially CNTs,
due to its low toxic effects and compatibility. Well-dispersed, freestanding GO nanosheets have been
demonstrated to have the highest antibacterial effect among several GR-based nanomaterials. Here,
the antibacterial activity of GO coatings against Escherichia coli showed higher activity than that against
Staphylococcus aureus. The sharp edge of GO, which was at a perpendicular position to the bacteria,
caused greater damage to S. aureus in direct contact than to E. coli due to the absence of any additional
outer membrane in the case of S. aureus. However, E. coli was more damaged by the GO coatings than
S. aureus. Taking into account the structure of bacterial cell wall, oxidative stress from GO more easily
penetrated through the thinner cell wall of E. coli. The disruption of the cell by GO coatings without
sharp edges was further confirmed by a change of bacterial morphology after exposure to the coating.
The membrane integrity of the cell was lost, and cytoplasm was leaked, resulting in final cell death.
Considering the morphological properties of GO coverings, in particular, that they are edge-free and
bonded in parallel to the given substrate, the ROS mechanism was considered as the principal factor of
antibacterial activity [100].
The antibacterial properties of GO have evoked broad concern in various medical branches, in
spite of the exact antibacterial mode of action of GO not being discovered thus far. While investigating
the interactions of GO with gram-positive and gram-negative bacteria, it was ascertained that the
transformation of GR to GO and the associated antimicrobial effects of GO are concentration and
time-dependent. The loss of bacterial membrane integrity increases with rising GO concentrations,
which conform to the increased release of lactose dehydrogenase in the medium. Differences in the
GO mode of action in relation to gram-positive and gram-negative bacteria were apparent with cell
captures, which were mainly with gram-positive S. aureus and Enterococcus faecalis, while membrane
contravention, because of physical contact, was found for gram-negative E. coli and Pseudomonas
aeruginosa. According to ATR-FTIR characterization, changes in the fatty acids, amides I and II of
proteins, peptides, and amino acid regions of GO-treated bacterial cells were observed when compared
to untreated bacterial cells. Thus, these data further explain the antibacterial effect of GO against
bacteria. Figure 10 represents possible interactions of GO with membranes of gram-positive and
gram-negative bacteria strains [102].
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Hydrogels [103–105], especially those with a combination of GO and PEG, are characterized by
good biocompatibility and an intrinsic antimicrobial activity, and are perspective colloidal building
blocks for the fabrication of 3D materials, which are increasingly used in the encapsulation and delivery
of drugs and cells. Cheng et al. prepared a colloidal injection hydrogel composed of GO. The reversible
folding of this product is due to pH-dependent hydrogen bonds. The formulation has high antibacterial
activity and possesses a good drug release ability [106].
Rasoulzadehzali and Namazi demonstrated the antimicrobial efficacy of pH-sensitive bio-NC
hydrogel beads made of CS and GO-Ag nanohybrid particles for the controlled release of doxorubicin
(DOX) towards gram-positive and gram-negative bacteria, studying the anticancer effect as well [107].
A GO-CS-Ag NC, fabricated by the agitation of CS with GO nanosheets synthesized using Hummers’
method, with Ag NPs fabricated from a green tea leaf extract, was tested against S. aureus, Streptococcus
mutans, E. coli, Klebsiella pneumoniae, P. aeruginosa, and Salmonella typhi. In addition, the antibacterial
activity of the starting materials and intermediates was investigated. The nanomaterials demonstrated
significant antibacterial potency, efficiently inhibiting the growth of pathogenic bacterial strains.
However, the antibacterial effect decreased in the following order: GO-CS-Ag > GO-Ag > GO-CS >
GO. This result suggests that the newly developed GO-CS-Ag nanosystem can potentially be applied
in biomaterials for biomedical and food purposes [58].
Antimicrobial electrospun mats, fabricated from the dip coating of a PLA nanofiber into a GO
covered by dopamine (DMA) (PLA-GO-DMA), have been proven to have an antibacterial effect towards
E. coli and S. aureus. Moreover, the biocompatibility of the mats was studied using HUVECC and the
HepG2 and A549 cell lines in PLA-GO-DMA, demonstrating significant biocompatibility [108].
Prepared poly(ethylene glycol-amine)-derivatized GO nanosheets labelled with fluorescein
isothiocyanate (FITC-PEG-GO) were effectively absorbed by peritoneal macrophages, causing a
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considerable increase in the phagocytosis of the important opportunistic fungal pathogen Candida
albicans by pro-inflammatory M1 and reparative M2 macrophages. Treatment with GO increases M1
macrophage activation, which is considerable for the eradication of pathogens, and decreases alternative
M2 macrophage activation, which decreases fungal persistence and inhibits chronic infectious diseases.
This higher fungicide potency of macrophages after GO treatment seems to be promising for future
treatments [109].
Sandhya et al. prepared rGO via reduction based on potato starch and zinc oxide coated rGO
(ZnO-rGO). In this case of ZnO-rGO, the reduction and the conversion of ZnO to nano-ZnO occurs
simultaneously. The antibacterial effect of the materials towards E. coli was tested. The results
demonstrated that ZnO-rGO has better antibacterial properties than rGO, which was attributed to
the synergistic effect of ZnO and rGO towards the bacteria in the NC. It was also found that the
antibacterial activity of ZnO-rGO against E. coli is associated with the disruption of the bacterial cell,
which was confirmed by AFM images [110].
Frequently, antibacterially-active nanosystems are used in combination with antibacterially-active
drugs [92,95,111]. Multiple mechanisms of action provide the synergistic activity of such combinations,
preventing the occurrence of resistant or multidrug resistant strains, or even successfully destroying
such pathogens. For example, tyramine-conjugated GO (GOTA)-immobilized TiO2 was developed
for orthopedic applications, with the purpose of efficiently transferring and releasing antimicrobial
agents, preventing implant-associated infection. Subsequently, doxycycline (DXC) was loaded onto
GOTA/TiO2 via non-covalent bonds. The DXC/GOTA/TiO2 NC contained 36 µg of DXC per cm2,
and it was ascertained in in vitro experiments that the sustained release of DXC from the TiO2 surfaces
continued for more than 30 days. DXC/GOTA/TiO2 demonstrated higher antibacterial activity against
E. coli and S. aureus than bare TiO2 and GOTA/TiO2, without any damage to the viability of human
dermal fibroblasts [112]. Ma et al. investigated the release of ciprofloxacin (CPX) from GO and rGO
in the presence of MMT in simulated gastrointestinal fluids. The order of adsorption affinity of CPX
was as follows: rGO + MMT > GO + MMT > rGO + MMT + pepsin > rGO > GO + MMT + pepsin
> MMT > MMT + pepsin > GO > rGO + pepsin > GO + pepsin. MMT increased the adsorption
of CPX on GO and rGO, owing to the hydrated coating of Si on the GO and rGO in the simulated
gastric fluid. CPX was adsorbed by GO and rGO and the adsorbed CPX was liberated from MMT
into solution by electrostatic repulsion. The reduced CPX ratio was lowest in the GO/rGO + MMT +
pepsin system. A mixture of MMT and GO/rGO reduced the CPX concentration in the gastric fluid,
which consequently results in the low antibiotic activity of CPX [113].
GO covered with mannose and PEG (GO-PEG-MAN) has been shown, in vitro, to have an
enhanced intake of macrophages by using mannose receptor-mediated endocytosis. Rifampicin
(RIF) uptake was considerably increased when loaded with GO-PEG-MAN, causing an increase
of RIF concentration in macrophages, lasting for a long period, leading to a more elimination of
intracellular Mycobacterium tuberculosis. Moreover, based on the above-mentioned fact, MAN-GO DDS
was suggested for the removal of macrophage ablation in atherosclerotic plaque [114].
Hybrid systems, prepared from the antitubercular agents isoniazid and pyrazine-2-carbohydrazide,
covalently linked to GO, were developed to obtain a multi-target hybrid system with enhanced
antimycobacterial effects and a broader range of activities, including being effective against bacterial
(from the ESKAPE list) and fungal strains. The NCs were tested against mycobacterial, bacterial, and
fungal strains, and their microbicidal effect was determined to be caused by the induction of membrane
depolarization. The toxicity of the agents to Hep-2 was insignificant at tuberculostatic concentrations.
The NCs were able to suppress resistance and enhance the effect of first-line drugs against tuberculosis.
The high antimycobacterial efficacy of GO, its synergism with isoniazid, and the main anti-biofilm
effect were observed for combinations between GO and the two first-line tuberculostatics [115].
Unfortunately, GO has also been reported to be toxic to mammalian cells. For example, Singh et al.
described the thrombotoxicity of GO in mice, also elucidating the evocation aggregation response in
human platelets [71]. The surface of GO determined the biocompatibility, which was used in preparation
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to formulate variously functionalized GO. Amine-functionalized GO sheets demonstrated insignificant
cellular toxicity. These opposite properties seem to be connected with the surface charge [116–119],
characterized by, for example, the zeta-potential. Based on the performed measurements, the GO was
shown to be negatively charged in the pH range from 3.5 to 9. This was determined to be caused by
carboxylic moieties. Amino-modified sheets demonstrated a positive charge when the pH was less
than 10. The effect of surface functionalization of GO on bacterial efficacy and toxicity on human cells
has also been described, for example, by Valentini et al. [120].
The applications of GR, GO, and rGO as antimicrobial agents are limited (besides frequent
mammalian cell toxicity) by their aggregation, which is caused by van der Waals interactions between
sheets. Additionally, this effect can be prevented by the functionalization of the surface of nanomaterials.
Detailed information on the possibilities and types of modifications of surfaces of GR, GO, and rGO
by metals and/or their oxides, metalloids, natural and synthetic polymers, antibiotics, enzymes, and
their behavior as solids and in solution have been described by Kumar et al. in their comprehensive
review [121].
8. Drug Delivery Systems
Delivery systems are specific formulations that are used to transfer/deliver biologically active
ingredients/agents in plants or animal/human organisms to a target/specific site/tissue of action, in order
to provide a specific release of the active agent upon delivery, or to ensure the stability of the active
agent up until it is delivered to the correct location. In biomedical applications, delivery systems are
mainly used for drugs, proteins, and genes [104,105,122–126].
GR can interact with proteins in biological fluids, which may result in significant changes of
the molecular physical characteristics and cause harmful reactions in the host’s immune system.
The chemical properties of GR and its membrane interactions result in direct toxicity not only to the
target but also to neighboring cells. Given the benzene structure of the hexagonal components of the
lattice, it can be considered a huge aromatic poly molecule or intact GR, where pi-pi and hydrophobic
forces are the main source of drug binding, however, for other forms of GR, the presence of functional
groups provides more possible interactions. Because of this, the use of non-functionalized GR in
biomedical applications is limited and other forms based on GR are used [127]. The unstable structure,
negative charge, and poor cellular uptake of genes make the usage of a carrier necessary for their
protection and transport. GR NPs covered by guanidine and amine moieties possess better potential
for coupling with genes (i.e., in DNA or RNA) [27].
Targeted drug delivery can improve the bioavailability, biocompatibility, and safety of therapeutic
agents [104,105,123,124,126,128]. This can help solve the problems connected with the treatment of
cancer, by reducing the systemic “intrinsic” toxicity of the drug itself (which is a limitation factor of
therapy, due to the size of the dose) and, in such a way, overcome undesired side effects [104,105,123,127].
DDSs can also help to overcome the resistance of the cells to the drug [92,104,105,123]. Ideal DDSs
are able to deliver a drug to the site of action, control the sustained release of the drug, and protect
the drug from degradation. Such DDSs have suitable physicochemical properties that allow their
transport in the body, while their specific properties facilitate cell-specific absorption and delivery [104].
Recent trends favor highly-customized NPs, with the control of each physicochemical property, such
as the particle size and shape, zeta potential, specific surface area, etc. Nano-carriers increase drug
concentrations in cancer cells using both passive and active targeting strategies. This reduces the
toxicity to healthy cells. Passive targeting is enabled by increased permeation and retention. Active
targeting utilizes specific interactions between the drug carrier and target cells. Nano-carriers are
often coated with a variety of ligands that bind to cancer-specific receptors, thus allowing systems to
enter the cell through receptor-mediated endocytosis. Covering the NP surface with a biocompatible
polymer (e.g., PEG) extends the blood circulation time by preventing opsonization and decreasing
absorption by the reticuloendothelial system. Thus, increasing the distribution of the NP into the target
tissue is realized, which gives rise to the capability of functional groups (e.g., bis-amine) on the surface
Nanomaterials 2019, 9, 1758 20 of 37
to be conjugated with other ligands [129]. Some ligand-receptor targeted DDSs have been studied,
such as interleukin, lipoprotein, Fc receptors, lectin, complement, transferrin receptors, and receptors
(e.g., dopamine) expressed in, for example, human colon adenocarcinoma and breast cancer. Thus, it is
possible to efficiently deliver anticancer drugs through nanosupports and overcome the overall toxicity
problems using active and passive targeting mechanisms [34,35]. In addition, various nanosystems can
ensure higher efficacy and a lower recurrence rate for combined therapy, including the use of radiation
therapy, photodynamic therapy (PDT), photothermal therapy (PTT), and chemotherapy. For combined
therapy, multifunctional nanomaterials are becoming of interest due to their effective ability of drug
loading, targeted delivery, and controlled drug release [123].
DDSs include nanostructures or nanomaterials such as liposomes, micelles, branched polymers,
dendrimers, microspheres, polymer shells, magnetic NPs, metal NPs, quantum dots, various other
inorganic NPs, and CNTs, GR-based materials, fullerenes, nanodiamonds, etc. [103,105,123].
At this point, multimodal drug delivery needs to be introduced. These are specifically designed
NP systems that are capable of providing multiple functions and are not simply “classic” DDSs.
Multimodal DDSs are capable of, for example, immune modulation and intracellular drug delivery or,
in addition to drug delivery, also serve as various probes for diagnosis or imaging. The condition is
that these systems should not be toxic to macrophages [130–132]. The multimodal DDSs were born
from the idea that biological phenomena including inflammation, angiogenesis, and tissue remodeling
are quite complex. The interlinked processes are also regulated by the spatiotemporal manner of
biological processes [130]. The factors in the local microenvironment are elaborated and followed by
a defined path. For this reason, the single-factor delivery oversimplifies biology and has not been
proven to be clinically effective in pathological states. In this regard, the strategies of delivery of
several factors to modulate several stages have paved the way for the pathology. The multiple delivery
system, including a number of strategies, offers opportunities for a temporal multi-modal release.
These strategies are of importance and have been demonstrated as methodologies [133].
GR therapeutics are used for both diagnostic and therapeutic applications [134–136]. One of the
first biomedical GR utilizations was for drug delivery. GR-based systems are used in drug-based
chemotherapy, phototherapy, gene therapy, and radiotherapy. Great effort has been devoted to design
NCs that combine the ability to detect cancer cells at an early stage with effective imaging, drug storage,
and controllable drug release [13,137]. Photothermal and redox-responsive DDSs have been designed,
covering mesoporous silica nanoparticles (MSNs) with GR quantum dots (GRQDs). The MSNs loaded
by rhodamine B (RhB) and GRQDs, capped on MSNs as gatekeepers, can inhibit the loosening of
RhB. NCs with a size of about 100 nm have an excellent photothermal ability, originating from the
GRQDs. In addition, the NCs had an interesting redox reaction to glutathione from disulfide bridges
(created by an amino functionalized MSNs amidation cystine), and thus, the loaded drugs could be
released in a controllable manner [138]. Cancer cells excrete lactic acid, which leads to low pH values
in cancerous environments. The covering of GO by wedelolactone (Wed) and indocyanine green (ICG)
by pi-pi interaction has been shown to result in the generation of an ICG-Wed-GO multifunctional
anticancer DDS for controlling trimodal synergistic therapy consisting of chemotherapeutic therapy,
PTT, and PDT. Wed is a polyphenolic compound, isolated from Wedelia calandulaceae or Eclipta prostrata,
having broad anti-tumor effects through the binding of dsDNA, inhibiting topoisomerase IIα, and
blocking DNA synthesis. ICG-Wed-GO NC effectively absorbs near infrared (NIR) laser irradiation and
transforms optical energy to heat, generating/ablating reactive oxygen species (ROS), leading to the
destruction of tumors. It has been shown that after treatment for 14 days with ICG-Wed-GO and NIR,
cancer cells were completely lost in tumor-bearing mice. Furthermore, the insignificant ICG-Wed-GO
toxic effect has been established [139]. The ability of GO to change its fluorescence at visible/NIR
wavelengths as a function of pH was applied to scan cancerous tissues. For example, Campbell et al.
described this type of DDS as a new multifunctional agent for the delivery, imaging, and detection
of tumor environments [140]. GO is able to detect the acidic extracellular tumor environments of
the HeLa and MCF-7 cells in comparison with non-cancer HEK-293 cells, and possesses excellent
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characteristics, such as its chemical and optical properties, easy functionalization, large surface area,
high thermal stability, suitable conductivity, and larger range of biomedical applications [6]. In addition
to detection, GO can protect gene therapeutics from nuclease degradation and streamline treatment
by increasing intracellular drug delivery that can be covalently or non-covalently associated with
various functionalization approaches [140]. For example, hybrid miRNA provides GO with positive
functional groups that could take superiority over targeting and PTT when suppressing cancer cells [27].
MicroRNA-101 (miR-101) is a significant regulatory factor that is downregulated in various cancer types,
such as prostate, liver, lung, breast, pancreatic cancer, bladder, and colon cancer. miR-101 is a regulator
of autophagy, apoptosis, metastasis, cellular stress, and cancer cell growth. Influencing genes, such as
Stathmin1 with miR-101, function as apoptotic accelerators and autophagic suppressors. Peptides, such
as cell penetrating peptides, e.g., poly-l-arginine (P-l-Arg), are not only internalized into the cell but
also can swiftly transport nanostructures. GO molecules covalently decorated with PEG and P-l-Arg,
which are able to reduce the surface of GO and increase NIR absorption by approximately 7.5-fold as
compared to that of non-reduced GO, are perspective biomolecules for killing tumor cells by regulating
various cell functions, such as proliferation, apoptosis, metastasis, differentiation, autophagy, invasion,
and stress. GO-PEG-(P-l-Arg) has a higher payload of miRNA, greater internalization, and facilitates
endosomal to fall into the cytoplasm as compared to GO-PEG. In addition, the application of P-l-Arg
has been shown to increase the selective transfection of systems in tumors (MCF7, MDA-MB-231) as
compared to immortalized breast and fibroblast cells. The application of GO-PEG-(P-l-Arg)/miR-101
and NIR irradiation has been shown to induce a 68% occurrence of apoptosis in cancer cells and
suppress the Stathmin1 protein [27,65].
Yuan et al. designed CS-coated microspheres, prepared from konjac glucomannan/sodium
alginate/GO injected into CaCl2 solution with the help of high voltage static electricity, as colon-targeted
delivery systems. The performed tests suggest that the CS membrane improved the stability of
microspheres and GO ensured a high loading capacity for drugs [141]. On the other hand, other defects
can be found that complicate the further use of GO as a drug carrier in the treatment of cancer.
Firstly, GO is easily aggregated in electrolyte solutions, e.g., buffered saline. Secondly, drugs could
not be effectively released from GO-based DDS due to pi-pi GO-drug binding (which is usually
<40%). Third, untargeted drug release causes adverse effects on healthy cells. Various attempts
to solve these problems have been made, for example, to modify GO by PEG to increase the
stability of GO. The natural structure of GO destroys covalent bonds. Conversely, non-covalent
methods disrupt the internal structure of GO and are therefore more versatile and sensible than
covalent methods [142]. Drug release systems can be modulated by stimulus-responsive systems,
i.e., specific signals (pH, redox potential, temperature, and light). Redox-responsive systems are
such carriers. These include redox-sensitive bonds (e.g., disulfide bond) that are stable in non-tumor
tissues/cells but can be cleaved in a redox-triggered microenvironment. Figure 11 represents an active
tumor-targeting and redox-sensitive release of DOX based on a complex of GO and PP which is formed
by methoxypoly(ethylene glycol) (mPEG) as a hydrophilic part and poly(lactic-co-glycolic acid) (PLGA)
as a hydrophobic part. Furthermore, PP was conjugated with DOX through disulfide bonding (SS)
and mPEG with folic acid (FA). The resulting complex GO/PP-SS-DOX/PEG-FA showed that it has
sufficient dispersibility and that it can serve as a stabilizing agent of GO and an active carrier for a
target drug delivery [142].
The covalent interactions of the carboxyl groups of GO with the amine group of peptides or polymer
surface of rGO lead to a decrease of the content of oxygen, and, on the other hand, GO conductivity
was increased in the biological fluid. Thus, modification techniques such as the application of PEG
enhance the dispersity and solubility of GO, even when in salt or serum for a long time [24].
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Especially, anticancer drugs, but also drugs from different therapeutic classes, have become a part
of GR-based DDSs designed and developed by a number f scientific teams around the word. Multiple
examples of diff rent nanoformul tions with various therapeutic a ts based on GR, GO, and r
are iscussed below.
A DDS based o arginin -glycine-aspartic acid (RGD)-conjugated GRQDs was prepared and
used to load DOX. The DOX-RGD-GRQDs showed high pH dependent DOX release. Contrary to
free DOX, substantial cytotoxicity to human glioma U251 cells was exhibited by the investigated
conjugates within a broad range of DOX concentrations. The results of the cellular uptake of
DOX-RGD-GRQDs show that not only DOX, but also some GRQDs penetrated into cell nuclei after
16 h of incubation [143]. Ginsenoside Rh2 (triterpene glycoside saponin), a new anti-tumor natural
agent, extracted from ginsenosides, has been shown to inhibit the growth of some types of tumor cells,
including pancreatic, breast, gastric, and prostate cancer, as well as hepatocellular and skin squamous
cell carcinomas. Rh2-treated GO (GO-Rh2), lysine-treated highly porous GR (GR-Lys), arginine-treated
GR (GR-Arg), Rh2-treated GR-Lys (GR-Lys-Rh2), and Rh2–treated GR-Arg (GR-Arg-Rh2) were
developed by Zare-Zardini et al. Interestingly, the cytotoxic activity of GR-Arg, GR-Lys, GR-Arg-Rh2,
and GR-Lys-Rh2 against cancer cell lines was higher than that towards non-cancer cells (MSCs). GR-Arg
and GR-Lys showed fewer undesirable effects in comparison with non-functionalized GR [144].
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Galactosylated-CS/GO loaded with DOX has been demonstrated to possess a high drug loading
capacity (1.08 mg/mg drug per polymer), the ability of release of the given drug in a low pH
environment, and high cytotoxicity for HepG2 and SMMC-7721 cells. Figure 12 shows the preparation
of a galactosylated-CS/GO/DOX complex. [145].
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of galactosylated-CS/GO/DOX nanoparticles. Reprinted from [145] with permission from Elsevier,
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New hydrogel NC films with anti-tumor effects were designed by incorporating GQDs into a
carboxymethylcellulose hydrogel and using DOX as a model drug. The investigation of the DDS
revealed improvements in swelling in vitro, degradation, water vapor release, and the delivery of pH
sensitive drugs, along with insignificant toxicity towards blood tumor cells K562 [146]. Javanbakht et
al. prepared a carboxymethylcellulose/zinc-based metal-organic framework/GO NC loaded with DOX,
which demonstrated significant cytotoxicity to K562 cells and higher water solubility [147].
Using l-plenylalanine (Phe), β-cyclodextrin (β-CD) was grafted onto GO to improve its stability,
drug loading capacity, and biocompatibility. The loading efficiency of the GO-Phe-CD nanocarrier was
78.7%, while the capacity of DOX was 85.2%, and the DOX release rate in the acidic environment of the
cancer cells was high. Also, GO-Phe-CD was not toxic and GO-Phe-CD with DOX effectively killed
MCF-7 cells [148]. Hydrophilic nanospheres prepared from hydroxypropyl-β-CD (HP-β-CD) and
carboxylated GO (GO-COOH) were components of a novel GO-COO-HP-β-CD NC, suitable for use as
a DDS for lipophilic drugs with limited water solubility. The produced NC has been shown to possess
a high dexamethasone (DEX) loading capacity and degree of water solubility. In vitro cytotoxicity tests
proved that the nanospheres were not toxic and are suitable for intravenous use with suitable blood
compatibility. It was observed that the biological effects of DEX were not influenced by incorporation
into the NC [149].
Electroconductive polymeric films, comprised of hyaluronic acid, gelatin, and poly(ethylene
oxide) reinforced by rGO, were utilized in drug release studies to evaluate the suitability of the films as
drug carriers. These types of conductive biopolymers possess great potential for carrying drugs for
cardiac treatment and regeneration with the purpose to increase conductivity aberrations caused by
coronary heart disease and conduction in the heart block. The cardiovascular drug irbesartan was
loaded onto the polymeric films, providing the controlled and sustained release of the drug [150].
The application of Ca+2 and Ba+2 ions as crosslinking agents, CaCO3 particles as solid porogen,
rivastigmine (RIV, used for the therapy of Alzheimer’s disease), water-soluble tragacanth gum (GT) and
GO nanosheets allowed the production of spherical pH-sensitive porous hydrogel beads. The swelling
Nanomaterials 2019, 9, 1758 24 of 37
behavior of the beads was influenced by the cross-linker content, cross-linker type, composition of
beads, and pH. The in vitro release behavior of RIV from hydrogel beads was found to be significantly
pH-sensitive. The control of RIV release can be made via pH changes. The release accelerates when
increasing pH from 1.2 (<45% RIV released) to 7.4 (97% RIV released). This is due to ionization
of COOH groups in GO and GT at a high pH, which increases the swelling of the hydrogel beads.
Cytotoxicity analysis has shown that 98% of cells survive at a bead concentration <125 µg/mL. The GO
in the hydrogel caused an increase in swelling and capture efficiency and ensured the controlled release
of the entrapped drug [151].
A GO-alginate nanogel (AGD) was prepared in situ by incorporating DOX-loaded GO under acidic
as well as reducible conditions, simulating a extracellular tumor microenvironment and intracellular
components. The internalization of DOX and its long-term accumulation in A549 cells were both
improved by the nanogel application. In addition, the nanogel showed photothermal activity against
cancer cells. The preparation of AGD is shown in Figure 13 [152]. A GO modified by protamine sulfate
and a sodium alginate NC loaded with DOX was proven to have high water dispersibility, uptake by
MCF-7 cells, and cytotoxicity towards MCF-7 cells [153].Nanomaterials 2020, 10, x FOR PEER REVIEW 24 of 36 
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A dual-sensitivity DOX-based DDS, the surface of which was coated with disulfide bond
proapoptotic peptides (KLAKLAK)2 (KLA), was prepared with GO loaded via pi-pi bonding. The GO
carrier was coated by bovine serum albumin (BSA) and the DOX@GO-SS-KLA/BSA DDS, which was
stable in biological media, was prepared. The results showed that the reduction and pH inside the
cells, respectively, caused the release of KLA and DOX, and synergy was achieved [154].
Cisplatin (CisPt), a strong alkylating antitumor drug, was loaded to GO. CisPt-GO NPs, co-loaded
with an antisense microRNA-21 (Anti-miR-21), were tested as a potential RNAi agent. This NC
delivered anti-miR-21 and CisPt into A549 tumor cells, which led to strongly improved cell apoptosis
and therapeutic efficiency (Figure 14) [115].
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PEGylated GO, loaded with curcumin, as an anticancer drug, proved to be an excellent
controlled-release DDS for the delivery of curcumin [26]. The conjugation of PEG-PLGA, GO, and folic
acid (FA) with DOX, via a disulfide bond, provids a NC with enhanced stability under physiological
conditions and DOX liberation in the reductive environment of cancer cells. Targeting nanohybrids
showed considerable higher cytotoxicity in vitro than non-targeting nanohybrids. A considerable
in vivo antitumor effect was observed, with nearly no systemic toxicity in B16 tumor-bearing mice [137].
Alendronate-functionalized GO nanosheets (DOX@PEG-NGO-ALs) enhanced the deposition of
DOX in the metastasis of bones. The results indicate that the PEG-NGO-ALs DDS could be used for
the treatment of bone related disorders, e.g., osteoporosis and Paget’s disease [155].
Functionalized phthalic anhydride, with CS followed by 4-cyano, 4-[(phenylcarbothioyl) sulfanyl]
pentanoic acid as a chain transfer agent (CTA), to give a CS-CTA macroinitiator, was copolymerized
with a methacrylic acid monomer (MAA) to obtain a polyacrylic CS graft (methacrylic acid copolymer)
(CS-g-PMAA). This GO was used for the preparation of a copolymer, and the CS-g-PMAA/GO NC was
loaded with DOX. The experimental results confirmed the excellent biological and physicochemical
properties of the developed NC, which can be applied as a DDS for cancer chemotherapy [156].
A stimuli-responsive GO/polymer brush NC (GCANBNs), synthesized via the polymerization of
acrylated β-CD, acrylic acid, and N-isopfropylacrylamide from the GO surface, was loaded with both
DOX and methotrexate (MTX). Drug release observations demonstrated reasonable NC performance
with respect to temperature and pH sensitivity. In addition, the MTT study showed that filling
improved drug efficacy [157]. The functionalization of the GO surface with aminated triphenylamine
(A-TPA) and 1,3,5-benzenetricarbonyl trichloride (BT) led to the revitalization of its fluorescence
properties, and the NC was studied as a new fluorescent DDS. The toxicity of GO-A-TPA-BT NC on
human breast cancer cells T47D was investigated. The DDS was loaded with DOX, and the drug release
profile indicated that, at an acidic pH level, further release occurs, due to smaller interactions between
DOX and the hybrid [158]. A significant in vitro cytotoxic effect on breast cancer cells MDA-MB-231
was shown by GO-methyl acrylate (MA) NPs coated with FA and loaded with paclitaxel (PTX).
Moreover, in vivo (in DMBA induced breast cancer rats) studies were performed and demonstrated
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that treatment with this nanosystem regulates the levels of mitochondrial citric acid enzymes to be
near normal [159]. Two-dimensional CS polymerized GO and PVP polymerized GO NPs decorated
with FA and loaded with camptothecin (CPT) were prepared by Deb and Vimala. The study indicated
that CS-polymerized NPs were more suitable for biomedical applications in terms of their hemolysis,
anti-inflammatory properties, and cellular toxicity against MCF-7 cell lines compared to PVP [160].
GO functionalized with hydrophilic and biodegradable PVP orβ-CD was loaded with the water-soluble
aromatic anticancer drug SN-38 (7-ethyl-10-hydroxy camptothecin). The release of SN-38 loaded into
both GO-PVP and GO-β-CD via pi-pi bonding was tested in different media at pH 7 (water, neutral
medium), pH 5 (acidic buffer), and pH 12 (basic buffer). The carrying capacity and cytotoxic activity of
SN-38 loaded on the functionalized GO were both tested, and it was found that the cytotoxicity of
SN-38–GO–PVP against the human breast cancer cell MCF-7 was comparatively higher than that of the
free SN-38 and GO-β-CD [48]. Gefitinib and quercetin, loaded in combination into PVP-functionalized
GO NPs, tested in PA-1 ovarian cancer cells, were significantly more toxic than the systems loaded
with the individual drugs and the free drugs, and their effects were compared to those on IOSE-364
ovarian epithelial cells. The combined system afforded a stronger effect of the combinatorial approach
and a higher effectivity of chemotherapeutic delivery [25].
The treatment of solid prostate tumors by intratumorally-injected GO covered by PdNP
(GO-PdNPs) was found to be more effective in a prostate cancer PC3 xenograft mouse model
(PC3 cells) than GO or PdNPs alone. Apoptosis caused by the synergy of the photothermal effect and
generation of ROS was considerably enhanced by the NIR irradiation of the treated cells. In addition,
the insignificant toxicity on organs of GO-PdNPs was an advantage here [161]. GO functionalized
with FA and polyethyleneimine (PEI) provided FA-PEI-GO, which was intended to carry two new
copper (II) complexes into the folate-receptor-positive nasopharyngeal carcinoma cells HNE-1 and
CNE-2. The cytotoxicity of the complexes showed that the IC50 values towards the two cell lines
were 17.7 ± 1.2, 13.2 ± 1.9 and 6.7 ± 0.8, 2.9 ± 0.7 µM, respectively [162]. Alumina (AlO(OH)) induces
antibody-mediated immunity, but due to poor stimulation of cell-mediated immunity, it is not suitable
for tumor immunotherapy alone. However, it is important to note that AlO(OH)-modified GO
nanosheets (GO-AlO(OH)) can stimulate the cellular immune response [163].
The synthesis of a MGO as DDS is illustrated in Figure 15. A β-CD grafted MGO NC (β-CD-MGO)
was investigated for use as a DDS for DOX and MTX. The obtained drug loading efficiencies of the
DDS were approximately 37.4% and 23.4% for DOX and MTX, respectively. It was determined that the
NC has a better drug release behavior in cancer cells conditions than in non-cancer cell conditions.
The screening of toxicity showed that the NC, where cell viability is higher than 80%, is nontoxic for
K562 [164].
A CS/NC sodium alginate functionalized magnetic iron oxide GO (MGO-CS/SA) NC loaded with
DOX had a diameter of 0.5 µm, a thickness of 40–60 nm, and a drug content of 137% w/w. The system
had good solubility and the drug release was pH dependent. In vitro studies have shown the possibility
of magnetic targeting and the significant photothermal effect of the carrier. Here, system toxicity
was concentration-dependent [165]. PEGylated, CS-encapsulated, DOX-loaded oleylamine-modified
Fe3O4 (DOX/OA-Fe3O4@CS-PEG) NPs, as cancer-specific theranostics for targeted DOX delivery and
magnetic resonance (MR) imaging, designed by Xie et al., had a high drug loading capacity of 24.3%
and a saturation magnetization of 4.11 emu/g. The results of the in vitro evaluation showed that
the empty NC was cytocompatible, while DOX/OA-Fe3O4@CS-PEG increased penetration into the
nuclei of HepG2 and showed higher efficacy in comparison to free DOX [166]. The NC for GRQD
and Fe3O4, conjugated with concanavalin A, a lectin protein, provided GRQD-ConA@Fe3O4. This
multifunctional NC is able to detect HeLa cells with a dynamic linear range of 5 × 102 to 1 × 105
cells/mL, with a detection limit of 273 cell/mL. GQD-ConA@Fe3O4 is also suitable as a nanocarrier
for DOX. In the presence of a magnetic field, the DOX concentration in HeLa cells was more than
double. In addition, HeLa cells were 13% more sensitive to DOX in this system than normal cells,
confirming the selective role of concanavalin A [167]. The in vitro screening of multifunctional
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hydrophilic magnetic NPs based on egg yolk-functionalized Pluronic™ F-127 (GYSMNP@PF127),
with a particle size of 180 nm, a negative surface charge, and high hemocompatibility, showed a high
capacity of 91% w/w for DOX, with a high heating effect with an alternating (AC) magnetic field
(internal energy loss in the range of 2.1 to 2.7 nHm2/kg), a controlled release of the pH responsive
drug, and thermal stimulus (46% at the acidic pH of the tumor and 7% at the physiological pH) when
in an alternating magnetic field (MF) [168]. The multifunctional NPs, with a diameter of 71.8 nm
and zeta potential of −333.07 ± 0.07 mV, prepared from GO coated with superparamagnetic iron
oxide nanoparticles (SPIONs) and poly(lactic-co-glycolic acid) (PLGA), was able to load 3.04 ± 0.46%
radiosensitizing 5-iodine-2-deoxyuridine (IUdR) and provided targeted delivery to gliomas. The
saturation magnetization was 15.98 emu/g. Treatment with IUdR/GO/SPION/PLGA and external
magnetic field caused a reduction in cancer volume in rats compared to buffered saline, IudR, and
SPION/IUdR/NGO/PLGA-treated rats [169].
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CPT loaded to doubly decorated MSNs grafted with fluorescent conjugates, coated with
polydopamine (PDA) and GO layers, was investigated by Tran et al., in relation to targeted delivery
and controlled release. These multifunctional NPs demonstrated low cytotoxicity, but high cytotoxicity
against SH-SY5Y cells. GO-wrapped MSNs showed effective drug delivery, as GO wrapping enhanced
their photothermal heating effect, efficient endocytosis into cells, and dispensability in water solutions.
In addition, anti-human epidermal growth factor receptor-conjugated MSNs demonstrated a high
specificity, which led to more enhanced anti-tumor effects in vitro [170]. Bio aterials based on various
silicate derivatives are important as drug carriers. The in vitro antibacterial efficacy of GO-SiO2 and
rGO-SiO2 NCs against E. coli and S. aureus was observed, and rGO-SiO2 demonstrated a higher
antibacterial effect against both bacterial strains than GO-SiO2 NC [171].
A novel multifunctional fluorinated GO (FGO) nanocarrier surface, modified with oxygen groups,
and functionalized with FA pre-linked amino-polyethylene glycol (PEG), provided suitable solubility
and good targetability against tumor cells with FA receptors. Furthermore, FGO-PEG-FA can be
loaded with DOX and CPT either individually or together in a controlled manner. FGO also showed
photoluminescence and strong NIR absorbance. Therefore, these types of DDSs can additionally be
used as an effective PTT system. Based on these facts, a three-in-one therapy model was developed,
combining mixed drug treating and PTT. A synergistic chemo-photothermal therapy agent was also
found in case of PDA-doped mesoporous silica-coated reduced GO (rGO/MSN/PDA) loaded with
DOX. This NC showed high therapeutic effects against hepatocellular carcinoma cells [172].
Recently, GR-based NCs have had much attention paid to them in the context of anti-tumor
therapy, due to their rare physicochemical characteristics. The combination of CPT-loaded rGO-AgNPs,
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with a mean size of 10 nm, uniformly distributed on GR sheets, was evaluated against HeLa cells.
rGO-AgNPs strongly potentiated CPT-induced cytotoxicity, apoptosis, and autophagy in the HeLa cell
line. In effect, this NC can be used for the treatment of cervical tumors, with strong synergism with
CPT or any other antitumor agents [173].
9. Conclusions
Nanotechnology is regarded as one of the key technologies of the 21st century. Nanoscale
materials change their physical and chemical properties, and thus, old materials are commonly
innovated and used practically in all fields of human activity. Graphene is just one of these innovative
nanomaterials that been intensively investigated, similarly to other graphene-based nanomaterials.
These materials can be widely modified, and therefore, nanomaterials based on graphene can be applied
as ultrasensitive sensors, advanced catalysts, superadsorbents, and nanocomposites. They are used in
optoelectronics/electronics, chemical solar cells, fuel cells, supercapacitors, rapid charging/discharging
batteries, etc. In addition, these materials, depending on the relevant modification/substitution,
exhibit a broad spectrum of biological effects, ranging from antiproliferative (to help to suppress the
growth of microbial pathogens or cancer cells) effects, to materials suitable for tissue engineering
and regenerative medicine applications (e.g., to support stem cell growth and the proliferation and
differentiation of cells). Moreover, they have been widely investigated as delivery systems for the
controlled release and/or targeted delivery of drugs/agrochemicals in biomedical, pharmaceutical,
and agricultural applications. However, it should be noticed that graphene-based nanomaterials can
be considered as specific non-biodegradable/non-metabolizable materials that are able to generate
various adverse cellular/tissue effects, depending on the specific size of the nanomaterial and surface
modification, and, therefore, reactivity. They can be deposited in the human body or environment,
thus bringing potential environmental, health, and safety risks. Despite the aforementioned significant
benefits of nanomaterials in biomedical applications (e.g., drug delivery carriers), an increased level
of attention should be devoted to the potential “intrinsic” toxicity of these nanomedicines caused by
particle size, which is able, within side effects, to induce various pathological processes which can result
in various adverse/hazardous effects in animals and humans. Therefore, many materials are not suitable
due to their aforementioned toxicity, but some graphene-based materials have demonstrated many
benefits at acceptable toxicity levels, and thus appear to be promising areas for further development.
However, it will take a long time for any of these nanosystems to enter the market for biomedical
applications. In addition, all these innovative nanomaterials are highly efficient in a number of
non-biomedical applications, however, for their safe use, they must also have high stability to avoid
eventual additional environmental pollution.
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